HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$1.39
Day range
$1.30 - $1.39
Year range
$0.86 - $3.36
Market cap
79.96M USD
Avg Volume
209.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.62M | -4.60% |
Net income | -40.95M | -99.40% |
Net profit margin | — | — |
Earnings per share | -0.68 | -100.00% |
EBITDA | -41.73M | -71.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 143.37M | -44.96% |
Total assets | 171.90M | -40.50% |
Total liabilities | 54.82M | 21.91% |
Total equity | 117.08M | — |
Shares outstanding | 60.57M | — |
Price to book | 0.72 | — |
Return on assets | -55.46% | — |
Return on capital | -62.79% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -40.95M | -99.40% |
Cash from operations | -31.83M | -92.40% |
Cash from investing | 38.48M | 2.08% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 6.65M | -68.37% |
Free cash flow | -17.91M | -86.74% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
61
